All Atrial fibrillation articles
-
Hosted contentAnticoagulation management for elderly patients with NVAF, CKD and other comorbidities
This promotional webinar was organised and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals only.
Click HERE to view ELIQUIS (apixaban) prescribing information and adverse events reporting
Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK).
432-GB-2200204 May 2022 -
eLearning module
Transitioning eligible patients with NVAF from warfarin to direct oral anticoagulants—a patient case study
This promotional Learning module has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View adverse event reporting and prescribing information for Xarelto▼(rivaroxaban)
PP-XAR-GB-2415 January 2022 -
Animation
Changes to the NICE atrial fibrillation (AF) guideline and anticoagulation treatment options—what do they mean to you?
This promotional animation has been commissioned by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼ (rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-2154 December 2021 -
News
Renal decline slower with rivaroxaban than warfarin in patients with atrial fibrillation
Patients with atrial fibrillation report fewer adverse renal outcomes and a slower decline in renal function on rivaroxaban compared with warfarin
-
NICE guideline
NICE atrial fibrillation guideline
A clear summary of NICE’s guideline on atrial fibrillation management
-
News
NICE publishes new atrial fibrillation guideline
NICE’s new guideline Atrial fibrillation: diagnosis and management updates and replaces NICE guideline CG180, and includes recommendations for providing the best care and treatment for adults with atrial fibrillation
-
Independent professional body guideline
AWMSG advice on oral anticoagulation for non-valvular atrial fibrillation
Recommendations for primary care on the role of oral anticoagulant treatment in people with non-valvular atrial fibrillation.
-
SIGN guideline
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
-
News
Quality standard on AF updated by NICE
NICE has updated Quality Standard 93 on Atrial fibrillation.
